Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis

References

• Thorat MA, Cuzick J. Preventing invasive breast cancer using endocrine therapy. Breast. 2017;34(Suppl 1):S47–S54.
   PubMedGoogle Scholar
• Grover S, Martei YM, Puri P, et al. Breast Cancer and HIV in sub-saharan Africa: a complex relationship. J Glob Oncol. 2018;4:1–11.
   Web of Science ®Google Scholar
•  Agnieszka K , Marzena K , Katarzyna S,  et al. Primary and secondary prevention of breast cancer. Ann Agric Environ Med. 2017;24(4):549–553.
   PubMed Web of Science ®Google Scholar
• Geffken K, Spiegel S. Sphingosine kinase 1 in breast cancer. Adv Biol Regul. 2018;67:59–65.
   PubMedGoogle Scholar
• Chen S, Wang H, Huang Y F, et al. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer. Mol Cancer. 2017;16(1):128.
   PubMedGoogle Scholar
• Hao WY, Guo LW, Luo J, et al. LncRNA TUG1 promotes growth and metastasis of cholangiocarcinoma cells by inhibiting miR-29a. Cancer Manag Res. 2020;12:11103–11111.
   PubMed Web of Science ®Google Scholar
• Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2018;495(2):1594–1600.
   PubMed Web of Science ®Google Scholar
• Li H, Zhu L, Xu L, et al. Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer. Mol Carcinog. 2017;56(1):3–17.
   PubMed Web of Science ®Google Scholar
• Chen F, Liu L, Wang S. Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p. Cancer Cell Int. 2020;20:323.
   PubMed Web of Science ®Google Scholar
• Tian Q, Yan X, Yang L, et al. lncRNA NORAD promotes hepatocellular carcinoma progression via regulating miR-144-3p/SEPT2. Am J Transl Res. 2020;12(5):2257–2266.
   PubMed Web of Science ®Google Scholar
• Li J, Xu X, Wei C, et al. Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis. Int J Clin Exp Pathol. 2020;13(1):1–13.
   PubMed Web of Science ®Google Scholar
• Zhou K, Ou Q, Wang G, et al. High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-beta pathway. Cancer Cell Int. 2019;19(1):63.
   PubMedGoogle Scholar
• Zhong Q, Wang L, Qi Z, et al. Long non-coding RNA TUG1 modulates expression of elastin to relieve bronchopulmonary dysplasia via sponging miR-29a-3p. Front Pediatr. 2020;8:573099.
   PubMed Web of Science ®Google Scholar
• Tang W, Zhang X , Tan W, et al. miR-145-5p suppresses breast cancer progression by inhibiting SOX2. J Surg Res. 2019;236:278–287.
   PubMed Web of Science ®Google Scholar
• Zheng P, Dong L, Zhang B, et al. Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19. Histochem Cell Biol. 2019;19(1):281–291.
   Google Scholar
• Shahar T, Granit A, Zrihan D, et al. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients. J Neurooncol. 2016;130(3):413–422.
   PubMed Web of Science ®Google Scholar
• Chen H, Gao S, Cheng C. MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA. Hum Cell. 2018;31(4):300–309.
   PubMed Web of Science ®Google Scholar
• Guan X, Chen S, Liu Y, et al. PUM1 promotes ovarian cancer proliferation, migration and invasion. Biochem Biophys Res Commun. 2018;497(1):313–318.
   PubMed Web of Science ®Google Scholar
• Kilic Y, Celebiler AC, Sakizli M. Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer. Clin Transl Oncol. 2014;16(2):184–190.
   PubMed Web of Science ®Google Scholar
• Dai H, Shen K, Yang Y, et al. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells. Cell Death Dis. 2019;10(8):595.
   PubMedGoogle Scholar
• Ghasemi-Dehkordi P, Doosti A, Jami MS. The functions of azurin of Pseudomonas aeruginosa and human mammaglobin-A on proapoptotic and cell cycle regulatory genes expression in the MCF-7 breast cancer cell line. Saudi J Biol Sci. 2020;27(9):2308–2317.
   PubMed Web of Science ®Google Scholar
• Du L, Liu X, Ren Y, et al. Loss of SIRT4 promotes the self-renewal of breast cancer stem cells. Theranostics. 2020;10(21):9458–9476.
   PubMed Web of Science ®Google Scholar
• Liao SA, Guan J, Mo H, et al. lncRNA LSINCT5 regulates mir-20a-5p/XIAP to inhibit the growth and metastasis of osteosarcoma cells. Onco Targets Ther. 2020;13:8209–8221.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Guo M, Shen M, et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020;36:101619.
   PubMed Web of Science ®Google Scholar
• Luo X, Liu X, Tao Q, et al. Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model. Oncol Lett. 2020;20(2):1400–1408.
   PubMed Web of Science ®Google Scholar
• Zhu J, Shi L, Du G, et al. Upregulated SET promotes cell survival through activating Akt/NF-kappaB signal in colorectal carcinoma. Cancer Manag Res. 2020;12:4735–4745.
   PubMed Web of Science ®Google Scholar
• Jaeckel S, Kaller M, Jackstadt R, et al. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells. Nat Commun. 2018;9(1):3573.
   PubMedGoogle Scholar
• Sun CC, Zhu W, Li S-J, et al. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1alpha pathway. Genome Med. 2020;12(1):77.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhou J, Zhao J, et al. The U2AF2/circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells. J Exp Clin Cancer Res. 2020;39(1):182.
   PubMed Web of Science ®Google Scholar
• Pu JT, Hu Z, Zhang DG, et al. MiR-654-3p suppresses non-small cell lung cancer tumourigenesis by inhibiting PLK4. Onco Targets Ther. 2020;13:7997–8008.
   PubMed Web of Science ®Google Scholar
• Warrier S, Tapia G, Goltsman D, et al. An update in breast cancer screening and management. Womens Health (Lond). 2016;12(2):229–239.
   PubMedGoogle Scholar
• Wu X, Lim ZF, Li ZW, et al. NORAD expression is associated with adverse prognosis in esophageal squamous cell carcinoma. Oncol Res Treat. 2017;40(6):370–374.
   PubMed Web of Science ®Google Scholar
• Tao W, Li Y, Zhu M, et al. LncRNA NORAD promotes proliferation and inhibits apoptosis of gastric cancer by regulating miR-214/Akt/mTOR axis. Onco Targets Ther. 2019;12:8841–8851.
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo H. Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer. J Int Med Res. 2019;47(8):3898–3904.
   PubMed Web of Science ®Google Scholar
• Klec C, Prinz F, Pichler M. Involvement of the long noncoding RNA NEAT1 in carcinogenesis. Mol Oncol. 2019;13(1):46–60.
   PubMed Web of Science ®Google Scholar
• Bw A, Lx A, Ju ZC, et al. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Biomed Pharmacother. 2020;129:110268.
   PubMed Web of Science ®Google Scholar
• Li J, Xu X, Meng S, et al. MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial-mesenchymal transition progression in bladder cancer. Cell Death Dis. 2017;8(8):e3010.
   PubMedGoogle Scholar
• Bjeije H, Soltani BM, Behmanesh M, et al. YWHAE long non-coding RNA competes with miR-323a-3p and miR-532-5p through activating K-Ras/Erk1/2 and PI3K/Akt signaling pathways in HCT116 cells. Hum Mol Genet. 2019;28(19):3219–3231.
   PubMed Web of Science ®Google Scholar